-+ 0.00%
-+ 0.00%
-+ 0.00%

KINASET THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2B PANAIRAMA TRIAL OF FREVECITINIB (KN-002) IN PATIENTS WITH SEVERE ASTHMA

路透·07/20/2026 12:02:49

登錄查看新聞詳情